Expertise in
2
conditions

Jianmin Xu

No. 180, Fenglin Road, 
Xuhui, CN 
Expertise in
2
conditions
No. 180, Fenglin Road, 
Xuhui, CN 

Overview

Jianmin Xu practices practicing medicine in Xuhui, China.

Xu is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Colorectal Cancer, Liver Cancer, PIK3CA-Related Overgrowth Spectrum, Hepatectomy, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 122 peer reviewed articles and participating in 5 clinical trials.

Locations

No. 180, Fenglin Road, Xuhui, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized Multicentric Phase III Trial Comparing Simple Surgery to Surgery Plus HIPEC (Hyperthermic Intraperitoneal Chemotherapy) With MMC in Colorectal Patients Who Have a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Randomized Multicentric Phase III Trial Comparing Simple Surgery to Surgery Plus HIPEC (Hyperthermic Intraperitoneal Chemotherapy) With MMC in Colorectal Patients Who Have a High Risk of Developing Colorectal Peritoneal Carcinomatosis
Enrollment Status: Completed
Publish Date: June 27, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy Versus Conventional Preoperative Radiochemotherapy for Locally Advanced Rectal Cancer With MRI Negative Circumferential Margin
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy Versus Conventional Preoperative Radiochemotherapy for Locally Advanced Rectal Cancer With MRI Negative Circumferential Margin
Enrollment Status: Suspended
Publish Date: May 11, 2022
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 3
Laparoscopic Versus Open Right Hemicolectomy in Treatment of Right-sided Colon Cancer Within an Enhanced Recovery After Surgery (ERAS) Protocol
Laparoscopic Versus Open Right Hemicolectomy in Treatment of Right-sided Colon Cancer Within an Enhanced Recovery After Surgery (ERAS) Protocol
Enrollment Status: Completed
Publish Date: March 22, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer (REAL): A Multicenter Randomized Controlled Trial
Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer (REAL): A Multicenter Randomized Controlled Trial
Enrollment Status: Unknown
Publish Date: March 22, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
A Single-centre, Prospective, Randomised, Controlled, Unblinded, Parallel-group Trial of Robotic-assisted Versus Laparoscopic Abdominoperineal Resection for the Curative Treatment of Low Rectal Cancer
A Single-centre, Prospective, Randomised, Controlled, Unblinded, Parallel-group Trial of Robotic-assisted Versus Laparoscopic Abdominoperineal Resection for the Curative Treatment of Low Rectal Cancer
Enrollment Status: Completed
Publish Date: March 09, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 4 Less Clinical Trials

121 Total Publications

Reply to: "Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?" and "Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?"
Reply to: "Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?" and "Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?"
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2026

Frequently Asked Questions about Jianmin Xu

Is Jianmin Xu a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Jianmin Xu is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jianmin Xu participate in research or clinical trials?

Yes. Jianmin Xu has published 121 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Jianmin Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xu's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile